| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 146, 635-642, Copyright © 1995 by American Society for Investigative Pathology
REGULAR ARTICLES |
M Barral-Netto, JS da Silva, A Barral and S Reed
School of Medicine, Federal University of Bahia, Brazil.
Resistance to and recovery from leishmania infection is dependent on cell-mediated immunity. C57BL/6 mice are resistant to Leishmania amazonensis (La) infection but susceptible to LP-BM5 murine leukemia virus (MuLV) infection. MuLV infection leads to a state of immunodeficiency characterized by severe compromise of cell-mediated immunity. When infected with La alone, C57BL/6 mice developed a small transient lesion that evolved to spontaneous healing or a lesion with extremely slow growth. Lesions were predominantly comprised of a lympho- macrophagic infiltrate with few parasitized macrophages. When infected with La and, 4 weeks later, with MuLV (La-MuLV), the mice developed a large uncontrolled nonhealing lesion containing vacuolated and heavily parasitized macrophages. In contrast, mice infected with MuLV first and La 4 weeks later (MuLV-La) developed a small but persistent lesion, characterized histologically by a small number of heavily parasitized macrophages and few lymphocytes. Eight weeks after MuLV infection, both had similar immunological profiles with decreased lymphocyte proliferation, diminished production of interferon-gamma, and high production of interleukins 4 and 10. At the time of L. amazonensis infection, La-MuLV animals have a normal T cell function whereas in MuLV-La mice this function is already impaired; this may influence the recruitment of macrophages to the site of leishmania injection.
This article has been cited by other articles:
![]() |
C. R. Teixeira, M. J. Teixeira, R. B. B. Gomes, C. S. Santos, B. B. Andrade, I. Raffaele-Netto, J. S. Silva, A. Guglielmotti, J. C. Miranda, A. Barral, et al. Saliva from Lutzomyia longipalpis Induces CC Chemokine Ligand 2/Monocyte Chemoattractant Protein-1 Expression and Macrophage Recruitment J. Immunol., December 15, 2005; 175(12): 8346 - 8353. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Brachelente, N. Muller, M. G. Doherr, U. Sattler, and M. Welle Cutaneous Leishmaniasis in Naturally Infected Dogs is Associated with a T Helper-2-biased Immune Response Vet. Pathol., February 1, 2005; 42(2): 166 - 175. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Khaskhely, M. Maruno, H. Uezato, A. Takamiyagi, S. T. Ramzi, K. M. A. Kasem, K.-i. Kariya, T. Toda, Y. Hashiguchi, E. A. G. Landires, et al. Low-Dose UVB Contributes to Host Resistance against Leishmania amazonensis Infection in Mice through Induction of Gamma Interferon and Tumor Necrosis Factor Alpha Cytokines Clin. Vaccine Immunol., May 1, 2002; 9(3): 677 - 686. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Umemura, K. Hirose, W. Wajjwalku, H. Nishimura, T. Matsuguchi, Y. Gotoh, M. Takahashi, M. Makino, and Y. Yoshikai Impaired IL-15 production associated with susceptibility of murine AIDS to mycobacterial infection J. Leukoc. Biol., January 1, 2001; 69(1): 138 - 148. [Abstract] [Full Text] |
||||
![]() |
H. R. Chakkalath, A. A. Siddiqui, A. H. Shankar, D. E. Dobson, S. M. Beverley, and R. G. Titus Priming of a beta -Galactosidase (beta -GAL)-Specific Type 1 Response in BALB/c Mice Infected with beta -GAL-Transfected Leishmania major Infect. Immun., February 1, 2000; 68(2): 809 - 814. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |